Canadian Centre on Substance Use and Addiction
Policy Brief

Brief Submitted to the Health Canada Consultation on the Potential Market for Cannabis Health Products that Would Not Require Practitioner Oversight

Outlines key considerations for cannabis health products. The brief argues that a public health focus should be maintained, that there is a need for greater scientific evidence to support health and safety claims of cannabis health products, and that youth access should be limited to reduce the normalization of cannabis products among this population. 

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.